Review
Open access
Aug 2026
Does Germline BRCA1/2 Status Modify the Effect of Neoadjuvant Pembrolizumab on Pathological Complete Response in Early-Stage Triple-Negative Breast Cancer? A Systematic Review and Meta-analysis of Treatment-Biomarker Interactions
The direction of effect is compatible with greater relative pembrolizumab-associated pCR improvement among carriers, but the evidence does not establish a predictive interaction.
I. M. A. Sandika, Made Oka Sastrawan, Ngurah Gede Boyke Arsa Wibawa
· Bioscientia Medicina : Journ... · 0 citations